Belarus enter the Russia-Ukraine war

'Bellum omnium contra omnes' - war of all against all - is a Hobbesian phrase which aptly reflects the current mindset of Belarus as they lay fearful of what Kyiv and the West intend to do. The Belarusian President Alexander Lukashenko said he has agreed to deploy a joint regional group of forces with Russia near the border with Ukraine. This strategic move serves to counter a growing threat he believes his nation is facing from Kyiv and the West.

"We were warned through unofficial channels yesterday about a trike to be delivered on Belarus from the territory of Ukraine" - President Alexander Lukashenko

The inclusion of Belarus in the war marks another uptick in tensions as the Russia-Ukraine war approaches its eighth month in force. Lukashenko has emphasised his country's preparation for the war by claiming he has "been preparing for a threat for decades" (WSJ, 2022). Remarks of this nature not only serve to highlight their readiness for the war but that the war will be more intense if Ukraine and the West continue to fight.

Belarusian President Alexander Lukashenko

Even though Belarus have justified entering the war on the grounds of the threat posed by Kyiv and the West, their reasoning in taking these actions is questionable. Moreover, what justifies entrance into a war of this kind? Is it popular belief in the war, a gross threat of invasion, or ideological necessity? An often-cited criterion is the principles of 'Jus Ad Bellum', meaning 'right to war'. This lists factors such as having just cause, being a last resort, being declared by proper authority, possessing right intention, having reasonable chance of success, and the end being proportional to the means used.

While this criterion is quite comprehensive, there is generally a sense of popular support for the war by citizens. This is true for most of history, and usually it is when popular support turns, such as the Vietnam War, that withdrawal becomes a priority.

However, even though Belarus is becoming involved in the Russia-Ukraine war, it is paradoxically not backed by popular support. Let's consider the statistics:

  • 74% of Belarusians, regardless of their political stances, had a negative attitude towards any Belarusian involvement in the war.
  • 79% of Belarusians think that the death of Belarusian soldiers during the war between Russia and Ukraine is unacceptable.
  • 50% of Belarusians believe that Belarus should remain neutral.

Whether this position will chance once Belarusian propaganda takes over public consciousness is yet to be seen. However, it is likely that the modern everyman will continue to hold a dovish stance on the war.

The implications in terms of international law for Belarus are vast. Firstly, a violation of the U.N. Charter, Chapter 1, Article 2(4) is likely as they were complicit in the invasion by violating the international prohibition against " the threat or use of force again the territorial integrity or political independence of any state." Also, Belarus is guilty of aggression according to the U.N.'s definition of "allowing its territory, which it has placed at the disposable of another State [Russia], to be used by that other state for perpetrating an aggression." There were violated even before Belarus decided to join the war.

Now, if they engage in the war, they will be liable for a host of other international crimes. However, the extent to which these can be enforced and whether Belarus/Russia will 'pay' for these crimes is an entirely different debate.

On the other hand, Article 51 of the U.N. Charter outlines that self-defence is an exception to the prohibition against the use of force. It is up for debate whether Belarus is in a situation where their involvement in the war could constitute 'self-defence'. However, it could very well justify their actions especially when considering the language they employ such as describing Kyiv and the West as a "threat".

As the world waits in suspense as to what the Belarus inclusion in this war exactly means, both sides will inevitably discuss strategies and tactics to maximise carnage. While popular support and international law hang in the air, their eventual fall is merely the subject of time.


To keep up with the latest finance, tech, crypto and geopolitical news, subscribe to our mailing list.

[Disclaimer: The material across our site is provided for informative purposes only and does not contain investment advice.]

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

May 8, 2026
Learn how professional investors analyse earnings reports by assessing revenue quality, margins, cash flow, balance sheet strength and management guidance.
By Debie Deslate May 7, 2026
Global energy risks are rising. Australia just committed $10.7 billion to respond. A closer look at the economic risks driving Australia’s push for greater fuel security.
May 6, 2026
The RBA has lifted rates to 4.35%. Here’s what it means for households, inflation, markets, sector performance and the outlook for Australian investors.
May 6, 2026
About The a2 Milk Co Ltd The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand. Source: EODHD Key Stats
May 5, 2026
About Meta Platforms Inc Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses in the United States, Canada, Europe, Asia-Pacific, and internationally. It operates through two segments, Family of Apps (FoA) and Reality Labs (RL). The FoA segment offers Facebook, which enables people to build community through feed, reels, stories, groups, marketplace, and other; Instagram that brings people closer through Instagram feed, stories, reels, live, and messaging; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; Meta AI, an assistant that's available across apps, as a stand-alone app, on AI glasses, and on the web; Threads, an application for text-based updates and public conversations; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact in a private way. The RL segment provides virtual and augmented reality products, including consumer hardware, software, and content that help people feel connected anytime and anywhere, as well as Meta Quest devices that enable social experiences across gaming, fitness, entertainment, and more. The segment also includes wearables such as AI glasses like Ray Ban Meta and Oakley Meta glasses, featuring Meta AI for advanced conversational and hands free interaction; and the Meta Ray Ban Display, which combines AI glasses with an integrated lens display and the Meta Neural Band, a wrist worn device using electromyography that lets people control their AI glasses through neuromuscular signals. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California. Source:EODHD Key Stats
May 5, 2026
About Amazon.com Inc Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, fire tablets, fire TVs, echo, ring, blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, Artificial intelligence, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Source:EODHD Key Stats
May 1, 2026
Earnings may beat expectations, but guidance drives markets. Learn how to read forward outlooks, tone and signals to better interpret stock price reactions.
May 1, 2026
About Visa Inc. Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, bank accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource and Authorize.net that provides new and enhanced payment integrations with ecommerce platforms, enabling sellers and acquirers to offer tailored commerce experiences; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Consumer Authentication Service, Visa Protect Authentication Intelligence, and Visa Provisioning Intelligence; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California. Source:EODHD Key Stats
May 1, 2026
About Telix Pharmaceuticals Ltd Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Source:EODHD Key Stats
April 30, 2026
The UAE leaves OPEC on 1 May. Oil prices did not move. Here is why the near-term calm is masking a structural shift investors should not ignore.